Population pharmacokinetic analysis of Datopotamab deruxtecan (Dato-DXd), a TROP2-targeting antibody-drug conjugate

Oncology

Trial design and analysis

Pharmacometrics

PAGE 32 (2024) Abstr 10859

Peigné S, Pan Y, Friberg Hietala S, Mc Laughlin AM, Tajima N, Uema D, Zebger-Gong H, Tang Z, Zhou D, Garimella T, Abutarif M, Hong Y